Title(s):
NRG-GU010 Parallel Phase III Randomized Trials of Genomic Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE) (NCT#05050084)
Investigator(s): Ashok Ramalingam, MD
Contact Information: McDowell Cancer Research at 330.344.6348
